INTERNAL INVOLVEMENT IN LOCALIZED SCLERODERMA

被引:47
作者
DEHEN, L [1 ]
ROUJEAU, JC [1 ]
COSNES, A [1 ]
REVUZ, J [1 ]
机构
[1] UNIV PARIS 12, HOP HENRI MONDOR, DEPT DERMATOL, F-94010 CRETEIL, FRANCE
关键词
D O I
10.1097/00005792-199409000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:241 / 245
页数:5
相关论文
共 33 条
[1]  
ABERER E, 1987, ACTA DERM-VENEREOL, V67, P225
[2]  
BIELSA I, 1985, MED CLIN-BARCELONA, V85, P171
[3]  
BOURGEOISDROIN C, 1978, ANN MED INTERNE, V129, P107
[4]  
BOURNERIAS I, 1991, ACTUALITE RHUMATOLOG, P11
[5]   ANTINUCLEAR ANTIBODIES .1. PATTERNS OF NUCLEAR IMMUNOFLUORESCENCE [J].
BURNHAM, TK ;
BANK, PW .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1974, 62 (05) :526-534
[6]   LOCALIZED SCLERODERMA - A CLINICAL STUDY OF 235 CASES [J].
CHRISTIANSON, HB ;
DORSEY, CS ;
OLEARY, PA ;
KIERLAND, RR .
ARCHIVES OF DERMATOLOGY, 1956, 74 (06) :629-639
[7]   THE PROGNOSIS OF LOCALIZED SCLERODERMA [J].
CURTIS, AC ;
JANSEN, TG .
ARCHIVES OF DERMATOLOGY, 1958, 78 (06) :749-757
[8]   ANTINUCLEAR AND ANTI-SINGLE-STRANDED DNA ANTIBODIES IN MORPHEA AND GENERALIZED MORPHEA [J].
FALANGA, V ;
MEDSGER, TA ;
REICHLIN, M .
ARCHIVES OF DERMATOLOGY, 1987, 123 (03) :350-353
[9]   LINEAR SCLERODERMA - CLINICAL SPECTRUM, PROGNOSIS, AND LABORATORY ABNORMALITIES [J].
FALANGA, V ;
MEDSGER, TA ;
REICHLIN, M ;
RODNAN, GP .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (06) :849-857
[10]  
FONTAN I, 1988, ANN DERMATOL VENER, V115, P135